Last reviewed · How we verify
NCT06191575
7 Tesla MRI Neuroimaging in Testicular Cancer Patients With Hypogonadism and on Androgen Replacement Therapy
trial testing 7 Tesla Magnetic Resonance Imaging in Hypogonadism in 10 participants. Suspended.
31 December 2026
Quick facts
| Lead sponsor | University of Southern California |
|---|---|
| Status | Suspended |
| Study type | OBSERVATIONAL |
| Enrollment | 10 |
| Start date | 29 November 2022 |
| Primary completion | 31 December 2026 |
| Estimated completion | 31 December 2027 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- 7 Tesla Magnetic Resonance Imaging
- Biospecimen Collection — full drug profile →
- Cognitive Assessment
Conditions studied
- Hypogonadism — all drugs for Hypogonadism →
- Malignant Testicular Germ Cell Tumor — all drugs for Malignant Testicular Germ Cell Tumor →
Sponsor
University of Southern California
Who can join
18 and older, male only, with Hypogonadism or Malignant Testicular Germ Cell Tumor. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study evaluates 7 Tesla (T) magnetic resonance imaging (MRI) in observing changes in the brain (neuroimaging) in testicular cancer patients who have decreased testosterone (hypogonadism) and are on testosterone (androgen) replacement therapy. Symptoms of hypogonadism can include fatigue, weakness, loss of libido, depression, poor concentration and erectile dysfunction. Some patients experience mental changes after diagnosis and treatment. There is some evidence that hypogonadism produces structural changes in the brain. The 7T MRI uses radio waves and a very powerful magnet linked to a computer to create detailed pictures of areas inside the body. This study may help researchers learn if 7T MRI can produce better images to assess the changes in the brain structure of testicular patients with hypogonadism and on androgen replacement therapy (ART).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06191575
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of 7 Tesla Magnetic Resonance Imaging
Trials testing the same drug.
- NCT04539574 — An Investigational Scan (7T MRI) for the Imaging of Central Nervous System Tumors · NA · completed
- NCT04318028 — An Investigational Scan (7 Tesla MRI) in Diagnosing Cognitive Impairment in Patients With Non-Metastatic Prostate Cancer · NA · completed
- NCT04330222 — Cambridge 7 Tesla Cerebral Small Vessel Disease Study · unknown
Other recruiting trials for Hypogonadism
Currently open trials in the same condition.
- NCT06455969 — Adaptions and Resiliency to Multi-Stressor OpeRations · Phase 4 · recruiting
- NCT06280807 — Observation of Environment and Reproductive-Endocrine Effects · recruiting
- NCT04460872 — Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury · Phase 2 · recruiting
- NCT04731376 — Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low Testo · Phase 1 · active not recruiting
- NCT03887936 — Testosterone Therapy and Bone Quality in Men With Diabetes and Hypogonadism · Phase 4 · active not recruiting
Other University of Southern California trials
Trials by the same sponsor.
- NCT07288463 — Hearing Loss and Genetic Risks for Alzheimer's Disease and Related Dementia · NA · not yet recruiting
- NCT05914233 — Non-invasive Ultrasound Retinal Stimulation for Vision Restoration · NA · not yet recruiting
- NCT06163664 — Role of ChatGPT in Vestibular Schwannoma Management · NA · withdrawn
- NCT07332312 — A Culturally Informed Patient Navigation Program (CFPN) to Reduce Delays Between Diagnosis and Treatment in American Ind · NA · not yet recruiting
- NCT07290478 — Encouraging Older Adults and Adults With Serious Illness to Designate a Health Care Proxy · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06191575 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Southern California
- Last refreshed: 22 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06191575.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing